Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: Literature review, qualitative scoring, and comparative analysis

Journal of Clinical Sleep Medicine

Volumn 6, Issue 1, 2010, Pages 79-83

  Hoque, Romy ^a   Chesson Jr , Andrew L ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Periodic limb movements of sleep; Pharmacologically induced; Rapid eye movement behavior disorder; REM sleep without atonia; Restless legs syndrome

Indexed keywords

AMFEBUTAMONE; CARBIDOPA; CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; LEVODOPA; LEVOTHYROXINE; MIANSERIN; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PERGOLIDE; PHENELZINE; SELEGILINE; SERTRALINE; TRAMADOL; VENLAFAXINE;

COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; HISTORY; HUMAN; LIMB MOVEMENT; MEDICAL LITERATURE; MOTOR DYSFUNCTION; NATIONAL HEALTH ORGANIZATION; NEUROLOGIC EXAMINATION; PARASOMNIA; PEER REVIEW; POPULATION SIZE; REM SLEEP; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT PLANNING;

EID: 77749270391     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27716     Document Type: Review

References (78)

1. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic & coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
2. O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgrad Med J 1993;69:701-3.
3. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200-3.
4. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-7.
5. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996;28:372-8.
6. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. Am J Kidney Dis 2004;43:763-71.
7. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology 2004;63:1065-9.
8. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 1996;19:670-2.
9. Gemignani F, Brindani F, Negrotti A, Vitetta F, Alfieri S, Marbini A. Restless legs syndrome and polyneuropathy. Mov Disord 2006;21:1254-7.
10. Gemignani F, Brindani F, Vitetta F, Marbini A, Calzetti S. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripher Nerv Syst 2007;12:50-3.
11. Tunc T, Karadag YS, Dogulu F, Inan LE. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 2007;22:627-31.
12. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002,53:547-54.
13. Lutz EG. Restless legs, anxiety and caffeinism. J Clin Psychiatry 1978;39:693-8.
14. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19.
15. Winkelman JW, Redline S, Baldwin CM, Resnick HE, Newman AB, Gottlieb DJ. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep 2009;32:772-8.
16. Aldrich MS, Shipley JE. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 1993;17:192-6.
17. Gann H, Feige B, Fasihi S, van Calker D, Voderholzer U, Riemann D. Periodic limb movements during sleep in alcohol dependent patients. Eur Arch Psychiatry Clin Neurosci 2002;252:124-9.
18. Stolz S, Aldrich M. REM sleep behavior disorder associated with caffeine abuse. Sleep Res 1991;20:341.
19. Vorona RD, Ware JC. Exacerbation of REM sleep behavior disorder by chocolate ingestion: a case report. Sleep Med 2002;3:365-7.
20. Dimmitt SB, Riley GJ. Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms. Arch Intern Med 2000:160:712.
21. Dedrick DL, Brown LK, Doggett JW, Guido PS. Lack of statistical association between antidepressant use and clinical restless legs syndrome in patients referred for insomnia. Sleep 2001;24(Abstrad Supplement):A365-66.
22. Leutgeb U, Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res 2002;7:368-78.
23. Brown LK, Dedrick DL, Doggett JW, Guido PS. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005;6:443-50.
24. Garvey MJ, Tollefson GD. Occurrence of myoclonus in patients treated with cydic antidepressants. Arch Gen Psychiatry 1987;44:269-72.
25. Husain MRG, Novak M, Jlndal R, Shapiro CM. Periodic leg movements in patients on different antidepressant therapies. Sleep Res 1997;26.
26. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005;58:510-4.
27. Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 1976;54:71-87.
28. Schenck CH, Mahowald MW, Kim SW, O'Connor KA, Hurwitz TD. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992;15:226-35.
29. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004;27:317-21.
30. Heiman EM, Christie M. Lithium-aggravated nocturnal myoclonus and restless legs syndrome. Am J Psychiatry 1986;143:1191-2.
31. Myers BA, Klerman GL, Hartmann E. Nodurnal cataclysms with myoclonus: a new side effect of clomipramine. Am J Psychiatry 1986;143:1490-1.
32. Terao T, Terao M, Yoshimura R, Abe K. Restless legs syndrome induced by lithium. Biol Psychiatry 1991;30:1167-70.
33. O'Sullivan RL, Greenberg DB. H2 antagonists, restless leg syndrome, and movement disorders. Psychosomatics 1993;34:530-2.
34. Bakshi R. Fluoxetine and restless legs syndrome. J Neurol Sci 1996;142:151-2.
35. Sanz-Fuentenebro FJ, Huidobro A, Tejadas-Rivas A. Restless legs syndrome and paroxetine. Acta Psychiatr Scand 1996;94:482-4.
36. Hargrave R, Beckley DJ. Restless leg syndrome exacerbated by sertraline. Psychosomatics 1998;39:177-8.
37. Horiguchi J, Yamashita H, Mizuno S, et al. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. Int Clin Psychopharmacol 1999;14:33-6.
38. Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999;19:478-9.
39. Bonin B, Vandel P, Kantelip JP. Mirtazapine and restless leg syndrome: a case report. Therapie 2000;55:655-6.
40. Agargun MY, Kara H, Ozbek H, Tombul T, Ozer OA. Restless legs syndrome induced by mirtazapine. J Clin Psychiatry 2002;63:1179.
41. Bahk WM, Pae CU, Chae JH, Jun TY, Kim KS. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci 2002;56:209-10.
42. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002;35:109-11.
43. Santamaria J, Iranzo A, Tolosa E. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep Med 2003;4:153-5.
44. Chen JT, Garda PA, Alldredge BK. Zonisamide-induced restless legs syndrome. Neurology 2003;60:147.
45. Tan EK, Ho SC, Koh L, Pavanni R. An urge to move with L-thyroxine: clinical, biochemical, and Polysomnographic correlation. Mov Disord 2004;19:1365-7.
46. Ozturk O, Eraslan D, Kumral E. Oxcarbazepine treatment for paroxetine-induced restless leg syndrome. Gen Hosp Psychiatry 2006;28:264-5.
47. Chang CC, Shiah IS, Chang HA, Mao WC. Does domperidone potentiate mirtazapine-associated restless legs syndrome? Prog Neuropsychopharmacol Biol Psychiatry 2006;30:316-8.
48. Perroud N, Lazignac C, Baleydier B, Cicottj A, Maris S, Damsa C. Restless legs syndrome induced by Citalopram: a psychiatric emergency? Gen Hosp Psychiatry 2007;29:724.
49. Abril B, Carlander B, Touchon J, Dauvilliers Y. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate? Sleep Med 2007;8:181-3.
50. Vetrugno R, La Morgia C, D'Angelo R, et al. Augmentation of restless legs syndrome with long-term tramadol treatment. Mov Disord 2007;22:424-7.
51. Page RL 2nd, Ruscin JM, Bainbridge JL, Brieke AA. Restless legs syndrome induced by escitalopram: case report and review of the literature. Pharmacotherapy 2008;28:271-80.
52. Prospero-Garcia KA, Torres-Ruiz A, Ramirez-Bermudez J, Velazquez-Moctezuma J, Arana-Lechuga Y, Teran-Perez G. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial. J Clin Psychiatry 2006;67:1820.
53. Salin-Pascual RJ, Galicia-Polo L, Drucker-Colin R. Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers. J Clin Psychiatry 1997;58:348-50.
54. Niiyama Y, Shimizu T, Abe M, Hishikawa Y. Cortical readivity in REM sleep with tonic mentalis EMG activity induced by clomipramine: an evaluation by slow vertex response. Electroencephalogr Clin Neurophysiol 1993;86:247-51.
55. Attarian HP, Schenck CH, Mahowald MW. Presumed REM sleep behavior disorder arising from cataplexy and wakeful dreaming. Sleep Med 2000;1:131-3.
56. Akindele MO, Evans JI, Oswald I. Mono-amine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol 1970;29:47-56.
57. Louden MB, Morehead MA, Schmidt HS. Adivation by selegiline (Eldepryle) of REM sleep behavior disorder in parkinsonism. W V Med J 1995;91:101.
58. Schutte S, Doghramji K. REM behavior disorder seen with venlafaxine (Effexor). Sleep Res 1996;25:364.
59. Onofrj M, Ludano AL, Thomas A, Iacono D, D'Andreamatteo G. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 2003;60:113-5.
60. Paik IH, Lee C, Choi BM, Chae YL, Kim CE. Mianserin-induced restless legs syndrome. Br J Psychiatry 1989;155:415-7.
61. Pae CU, Kim TS, Kim JJ, et al. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome? Psychiatry Clin Neurosci/2004;58:669-70.
62. Markkula J, Lauerma H. Mianserin and restless legs. Int Clin Psychopharmacol 1997;12:53-8.
63. Drake ME. Restless legs with antiepileptic drug therapy. Clin Neurol Neurosurg 1988;90:151-4.
64. Sackett DL Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol 1993;9:487-9.
65. Walters AS, Lavigne G, Hening W, et al. The scoring of movements in sleep. J Clin Sleep Med 2007;3:155-67.
66. Ware JC, Brown FW, Moorad J, Pittard JT, Murphy M, Franklin D. Nocturnal myoclonus and tricyclic antidepressants. Sleep Res 1984;13:72.
67. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:639-47.
68. Earley CJ, Allen RP. Restless legs syndrome augmentation associated with tramadol. Sleep Med 2006;7:592-3.
69. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006;108:477-81.
70. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-9.
71. Iber C, Ancoli-lsrael S, Chesson AL, Quan SF, eds. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1 ed. Westchester, Illinois: American Academy of Sleep Medicine, 2007.
72. Bental E, Lavie P, Sharf B. Severe hypermotility during sleep in treatment of cataplexy with clomipramine. Isr J Med Sci 1979;15:607-9.
73. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-move-ment (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol 1992;32:3-10.
74. Besset A. Effect of antidepressants on human sleep. Adv Biosci 1978;21:141-8.
75. Dib S, Ramos-Sepulveda A, Wohgemuth W, Gardener H, Lorenzo D, Wallace DM. Rapid eye movement sleep without atonia (RWA) in patients on serotonergic antidepressants (SA). Sleep 2008;31(Abstrad Supplement):A262.
76. Dorsey CM, Lukas SE, Cunningham SL. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 1996;14:437-42.
77. Carlander B, Touchon J, Ondze B, Billiard M. REM sleep behavior disorder induced by cholinergic treatment in Alzheimer's disease. J Sleep Res 1996;5(Supplement 1):28.
78. Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 1999;107:390-2.